Business
Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical
AUSTIN, Texas, July 25, 2025--Revival Healthcare Capital Announces Strategic Partnership with Olympus to Jointly Invest up to $458 Million into Swan EndoSurgical.
About this update from Olympus Corp.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1566,"height":413,"url":"https://media.zenfs.com/en/business-wire.com/5fde5eda0a5dc02ffa6d27b154927582"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EU3DJWZiTWLmnkgnKIjNCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5fde5eda0a5dc02ffa6d27b154927582","width":960,"height":253},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/QmGgPBUYXAakYkz6Jt.rJQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02MzI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/5fde5eda0a5dc02ffa6d27b154927582","width":1200,"height":316}},"lazy":false},{"type":"text","content":"AUSTIN, Texas, July 25, 2025--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a strategic partnership with Olympus Corporation (Olympus), a global healthcare leader committed to making people’s lives healthier, safer, and more fulfilling through advanced medical technologies and solutions, aimed at harnessing external innovation to accelerate development and market entry for an endoluminal robotics platform initially targeting gastrointestinal (GI) treatments.","length":584,"tagName":"p"},{"type":"text","content":"As part of the collaboration, Revival and Olympus co-founded Swan EndoSurgical, Inc. (Swan) and will jointly invest up to $458 million into Swan to develop a purpose-built endoluminal robotics platform which will seek to provide earlier, safer, and more effective treatment of lesions or tumors in the GI tract relative to current therapeutic options. The investment is tied to certain pre-agreed milestone events, with Revival taking a majority equity stake and controlling position alongside significant participation from Olympus. This is a structured investment which provides Olympus an option to acquire Swan at a predetermined value while Revival has protective rights if Olympus chooses not to exercise its option.","length":722,"tagName":"p"},{"type":"text","content":""We are proud to partner with Olympus on this strategic program and believe the partnership model with Olympus for Swan will aid in maximizing the value of external innovation, aiming to deliver on our p...